A dual PI3K/mTOR inhibitor as potential therapeutic option for vulvar cancer

被引：0
|
作者：
Rodrigues, Lara [1 ]
Rodrigues, Bruna [1 ]
Giudice, Fernanda [1 ]
Baiocchi, Glauco [1 ]
Soares, Fernando Augusto [1 ]
Martins, Vilma [1 ]
Rocha, Rafael Malagoli [1 ]
机构：
[1] FUNDACAO AC CAMARGO, Sao Paulo, Brazil
来源：
CANCER RESEARCH | 2015年 / 75卷
关键词：
D O I：
10.1158/1538-7445.AM2015-2662
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2662
引用
收藏
页数：1
相关论文
共 50 条
  • [31] The intersection of the PI3K/mTOR and HIPPO pathways: a potential therapeutic target for medulloblastoma
    Ronecker, Jennifer S.
    Lee, Paul
    Sridhara, Sudeepta
    LaBagnara, Michael
    Murali, Raj
    Jhanwar-Uniyal, Meena
    CANCER RESEARCH, 2016, 76
  • [32] Selective PI3K and dual PI3K/mTOR inhibitors enhance the efficacy of endocrine therapies in breast cancer models
    Friedman, L.
    Ross, L. B.
    Wallin, J.
    Guan, J.
    Prior, W. W.
    Wu, E.
    Nannini, M.
    Sampath, D.
    CANCER RESEARCH, 2012, 72
  • [33] A preclinical study of a PI3K/mTOR dual inhibitor in the treatment of esophageal adenocarcinoma.
    Omstead, Ashten N.
    Zaidi, Ali Hussainy
    Kosovec, Juliann E.
    Matsui, Daisuke
    Raj, Moses S.
    Biederman, Robert W. W.
    Finley, Gene Grant
    Kelly, Ronan Joseph
    Jobe, Blair A.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [34] Structural insights of a PI3K/mTOR dual inhibitor with the morpholino-triazine scaffold
    Takeda, Takako
    Wang, Yanli
    Bryant, Stephen
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2017, 253
  • [35] Therapeutic effect of gedatolisib, a pan-PI3K/mTOR inhibitor, on prostate cancer models with PI3K or PTEN mutational status.
    Sen, Adrish
    Khan, Salmaan A.
    MacNeil, Ian A.
    Rich, Benjamin E.
    Molden, Jhomary S.
    Davis, Laura N.
    Rossetti, Stefano
    Broege, Aaron M.
    Laing, Lance G.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41
  • [36] PI3K inhibitor GDC-0941 synergizes with mTOR inhibitors by blocking negative feedback and causes distinct effects on signaling and apoptosis compared to a dual PI3K/mTOR inhibitor
    Vijapurkar, Ulka
    Robillard, Liliane
    Friedman, Lou S.
    Belvin, Marcia P.
    CANCER RESEARCH, 2010, 70
  • [37] Discovery and research of a novel dual PI3K/mTOR inhibitor, DS-7423
    Shiose, Yoshinobu
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2013, 121 : 48P - 48P
  • [38] Identification of GNE-477, a potent and efficacious dual PI3K/mTOR inhibitor
    Heffron, Timothy P.
    Berry, Megan
    Castanedo, Georgette
    Chang, Christine
    Chuckowree, Irina
    Dotson, Jennafer
    Folkes, Adrian
    Gunzner, Janet
    Lesnick, John D.
    Lewis, Cristina
    Mathieu, Simon
    Nonomiya, Jim
    Olivero, Alan
    Pang, Jodie
    Peterson, David
    Salphati, Laurent
    Sampath, Deepak
    Sideris, Steve
    Sutherlin, Daniel P.
    Tsui, Vickie
    Wan, Nan Chi
    Wang, Shumei
    Wong, Susan
    Zhu, Bing-yan
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (08) : 2408 - 2411
  • [39] Dual PI3K and mTOR Inhibition in Waldenstrom Macroglobulinemia
    Husu, E. N.
    Roccaro, A. M.
    Anderson, K. C.
    Ghobrial, I. M.
    Leleu, X.
    Sacco, A.
    Melhem, M. R.
    Azab, A. K.
    Jia, X.
    Ngo, H. T.
    Azab, F.
    Runnels, J.
    Quang, P.
    CLINICAL LYMPHOMA & MYELOMA, 2009, 9 : S144 - S145
  • [40] Design and synthesis of dual PI3K/mTor inhibitors
    Olivero, Alan
    Heffron, Timothy
    Berry, Leanne
    Berry, Megan
    Castanedo, Georgette
    Chang, Christine
    Dotson, Jennafer
    Friedman, Lori
    Goldsmith, Richard
    Lesnick, John
    Lewis, Cristina
    Mathieu, Simon
    Nonomiya, Jim
    Pang, Jodie
    Peterson, David
    Prior, Wei Wei
    Salphati, Laurent
    Sampath, Deepak
    Sutherlin, Daniel
    Tsui, Vickie
    Ultsch, Mark
    Wang, Shumei
    Wiesmann, Christian
    Wong, Susan
    Zhu, Bing-Yan
    Chuckowree, Irina
    Folkes, Adrian
    Shuttleworth, Steve
    CANCER RESEARCH, 2009, 69
12345